首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌转移抑制基因1对卵巢癌细胞血管生成的影响及其机制探讨
引用本文:周映群,生秀杰,周冬梅,宋清源,刘启才. 乳腺癌转移抑制基因1对卵巢癌细胞血管生成的影响及其机制探讨[J]. 肿瘤防治研究, 2012, 39(9): 1046-1050. DOI: 10.3971/j.issn.1000-8578.2012.09.002
作者姓名:周映群  生秀杰  周冬梅  宋清源  刘启才
作者单位:1.510150 广州,广州医学院第三附属医院妇产科广东省产科重大疾病重点实验室;2.广州医学院实验医学研究中心
基金项目:广东省科技厅项目(2009B060700080);广州市科技计划资助项目(2010GN-E00221)
摘    要:目的探讨乳腺癌转移抑制基因1(breast cancer metastasis suppressor 1,BRMS1)对人卵巢癌细胞OVCAR3诱导血管内皮细胞形成管腔能力的影响及可能的机制。方法应用脂质体介导的方法将BRMS1 shRNA重组质粒转染人卵巢癌细胞OVCAR3,经G418筛选获得稳定转染株。荧光定量PCR和Western blot法检测BRMS1 mRNA和蛋白的表达水平;体外血管形成实验检测OVCAR3诱导人脐静脉内皮细胞(HUVECs)的血管形成能力;Western blot法检测生长抑制因子4(ING4)和白细胞介素-6(IL-6)的蛋白表达情况。结果稳定转染BRMS1 shRNA后,OVCAR3细胞BRMS1的表达在 mRNA和蛋白水平均受到明显抑制。体外血管形成实验提示,BRMS1表达下调后能显著促进卵巢癌细胞诱导的HUVECs形成管腔样结构的能力;Western blot法显示干扰组中ING4蛋白表达量较对照组下降30%,而IL-6蛋白表达上调,是空白对照组的1.5倍,差异有统计学意义(P<0.05)。结论干扰BRMS1基因的表达可促进卵巢癌细胞诱导血管形成能力,其机制可能与调节下游基因ING4和IL-6的表达有关。

关 键 词:卵巢肿瘤  RNA干扰  血管生成  乳腺癌转移抑制基因1  
收稿时间:2011-10-14;

Effects of Breast Cancer Metastasis Suppressor 1Gene on Angiogenesis of Human Ovarian Cancer Cell and Its Mechanism
Zhou Yingqun,Sheng Xiujie,Zhou Dongmei,Song Qingyuan,Liu Qicai. Effects of Breast Cancer Metastasis Suppressor 1Gene on Angiogenesis of Human Ovarian Cancer Cell and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2012, 39(9): 1046-1050. DOI: 10.3971/j.issn.1000-8578.2012.09.002
Authors:Zhou Yingqun  Sheng Xiujie  Zhou Dongmei  Song Qingyuan  Liu Qicai
Affiliation:1.Department of Obstetrics and Gynecology,The Third Affiliated Hospital of Guangzhou Medical College,Key Laboratory for Major Obstetric Diseases of Guangdong Province,Guangzhou 510150,China;2.Experimental Medical Research Center of Guangzhou Medical College
Abstract:Objective To investigate the effects and mechanism of breast cancer metastasis suppressor 1(BRMS1)on angiogenesis in human ovarian cancer cell line OVCAR3.Methods Vector containing a short hairpin RNA(shRNA)against BRMS1was constructed and the positive clone was named pGPU6/ GFP/Neo-BRMS1.The BRMS1shRNA or a non-specific sequence(as the negative control)was transfected into OVCAR3cells by LipofectamineTM2000and stably transfected cells were obtained by screening with G418.The expressions of BRMS1mRNA and protein in OVCAR3cells were performed using real time PCR and Western blot,respectively.Angiogenesis capacity of human umbilical venous endothelial cells(HUVECs)co-cultured with OVCAR3cells was determined by tube formation assay.Furthermore,the expressions of inhibitor of growth 4(ING4)and Interleukin-6(IL-6)were detected by Western blot.Results The recombinant plasmid could be successfully transferred into OVCAR3cells.Real time PCR and Western blot analyses demonstrated that BRMS1expression was efficiently down-regulated.Stable suppression of BRMS1in human ovarian cancer cells significantly promoted the ability of HUVECs to form tubular structures in the co-culture,and the number of tubules was markedly increased in transfection of BRMS1shRNA than that in the blank control group or negative control group.Moreover,the protein level of ING4in interference group was decreased by 30%,while BRMS1knockdown led to 1.5fold increase of IL-6protein expression(P<0.05).Conclusion Knockdown of BRMS1may play a critical role in promoting the angiogenesis-inducing ability of ovarian cancer cells,and BRMS1regulates metastatic potential at least in part through the regulation of ING4and IL-6.
Keywords:Ovarian neoplasms  RNA interference  Angiogenesis  BRMS1
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号